S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +0.88% S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +0.88%

LATEST

What Colombia’s July 20 Tax Reform Would Mean for Foreign Residents●LatAm Expat & Nomad Daily Guide for Sunday, July 12, 2026●₹2.45 to ₹213: Multibagger penny stock turns ₹1 lakh into ₹87 lakh in five years●NSE listing to "complete the trioka" and unlock value, drive governance upgrade: Report●Mcap of 4 of top-10 most valued firms jumps Rs 92,995 cr; HDFC Bank, Airtel top gainers●NSE launches Nifty500 Ahimsa Index based on non-violence towards animals; check stocks, methodology, other key details●This former U.S. soccer player built a $20 billion-a-year company. Now, he says resilience matters more than talent—and points to Lionel Messi as proof●Breaking: NGX meets FTSE Rusell, international investors in London over T+1 concerns●What Colombia’s July 20 Tax Reform Would Mean for Foreign Residents●LatAm Expat & Nomad Daily Guide for Sunday, July 12, 2026●₹2.45 to ₹213: Multibagger penny stock turns ₹1 lakh into ₹87 lakh in five years●NSE listing to "complete the trioka" and unlock value, drive governance upgrade: Report●Mcap of 4 of top-10 most valued firms jumps Rs 92,995 cr; HDFC Bank, Airtel top gainers●NSE launches Nifty500 Ahimsa Index based on non-violence towards animals; check stocks, methodology, other key details●This former U.S. soccer player built a $20 billion-a-year company. Now, he says resilience matters more than talent—and points to Lionel Messi as proof●Breaking: NGX meets FTSE Rusell, international investors in London over T+1 concerns●

Markets

AstraZeneca erases billions after sobering reveal

TST (Full) - (Official Feed) · 7h ago

AstraZeneca erases billions after sobering reveal

Drug trials fail all the time. What is rare is a failure that costs a company tens of billions of dollars in a single afternoon. That is what happened to AstraZeneca (AZN) on July 9. One setback wiped out more market value than the stock had lost on any day in years. For investors, the loss was ...

Read the full story at TST (Full) - (Official Feed) →

EUROS aggregates the world's financial press. The full article lives with the newsroom that reported it.

More Markets

Amazon has a $475 Citizen Eco-Drive luxury watch with 600+ feet of water resistance for 39% off

TST (Full) - (Official Feed) · 3h ago

AT&T stock price target cut puts dividend investors on alert

TST (Full) - (Official Feed) · 8h ago

Oracle’s stock split history explained

TST (Full) - (Official Feed) · 8h ago

Pizza chain closing up to 50 locations after years of declines

TST (Full) - (Official Feed) · 9h ago